A detailed history of Geode Capital Management, LLC transactions in Staar Surgical CO stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,174,499 shares of STAA stock, worth $30.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,174,499
Previous 1,143,287 2.73%
Holding current value
$30.9 Million
Previous $54.4 Million 19.84%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$29.97 - $47.42 $935,423 - $1.48 Million
31,212 Added 2.73%
1,174,499 $43.6 Million
Q2 2024

Aug 09, 2024

BUY
$38.07 - $52.25 $1.64 Million - $2.25 Million
43,105 Added 3.92%
1,143,287 $54.4 Million
Q1 2024

May 13, 2024

BUY
$27.67 - $39.61 $1.14 Million - $1.63 Million
41,182 Added 3.89%
1,100,182 $42.1 Million
Q4 2023

Feb 13, 2024

BUY
$30.6 - $43.78 $1.62 Million - $2.31 Million
52,787 Added 5.25%
1,059,000 $33.1 Million
Q3 2023

Nov 13, 2023

BUY
$39.39 - $58.12 $358,842 - $529,473
9,110 Added 0.91%
1,006,213 $40.4 Million
Q2 2023

Aug 11, 2023

BUY
$50.45 - $72.82 $2.8 Million - $4.04 Million
55,492 Added 5.89%
997,103 $52.4 Million
Q1 2023

May 15, 2023

BUY
$51.25 - $79.34 $2.03 Million - $3.15 Million
39,645 Added 4.4%
941,611 $60.2 Million
Q4 2022

Feb 13, 2023

BUY
$46.82 - $76.2 $1.45 Million - $2.36 Million
31,036 Added 3.56%
901,966 $43.8 Million
Q3 2022

Nov 14, 2022

BUY
$70.55 - $111.58 $1.36 Million - $2.15 Million
19,226 Added 2.26%
870,930 $61.4 Million
Q2 2022

Aug 12, 2022

SELL
$50.24 - $80.48 $9,143 - $14,647
-182 Reduced 0.02%
851,704 $60.4 Million
Q1 2022

May 13, 2022

SELL
$57.98 - $93.5 $35,251 - $56,848
-608 Reduced 0.07%
851,886 $68.1 Million
Q4 2021

Feb 11, 2022

BUY
$88.02 - $127.79 $2 Million - $2.91 Million
22,752 Added 2.74%
852,494 $77.8 Million
Q3 2021

Nov 12, 2021

BUY
$122.75 - $162.68 $431,957 - $572,470
3,519 Added 0.43%
829,742 $107 Million
Q2 2021

Aug 13, 2021

BUY
$105.76 - $154.96 $3.59 Million - $5.26 Million
33,917 Added 4.28%
826,223 $126 Million
Q1 2021

May 12, 2021

BUY
$78.5 - $126.48 $6.29 Million - $10.1 Million
80,083 Added 11.24%
792,306 $83.5 Million
Q4 2020

Feb 12, 2021

BUY
$55.93 - $82.78 $2.1 Million - $3.11 Million
37,559 Added 5.57%
712,223 $56.4 Million
Q3 2020

Nov 13, 2020

BUY
$45.65 - $61.81 $5.87 Million - $7.95 Million
128,641 Added 23.56%
674,664 $38.2 Million
Q2 2020

Aug 13, 2020

BUY
$29.15 - $61.54 $343,474 - $725,125
11,783 Added 2.21%
546,023 $33.6 Million
Q1 2020

May 14, 2020

BUY
$25.01 - $42.4 $1.29 Million - $2.2 Million
51,769 Added 10.73%
534,240 $17.2 Million
Q4 2019

Feb 13, 2020

BUY
$24.55 - $38.13 $553,921 - $860,327
22,563 Added 4.91%
482,471 $17 Million
Q3 2019

Nov 12, 2019

BUY
$25.78 - $34.8 $271,231 - $366,130
10,521 Added 2.34%
459,908 $11.9 Million
Q2 2019

Aug 14, 2019

BUY
$23.08 - $37.01 $88,304 - $141,600
3,826 Added 0.86%
449,387 $13.2 Million
Q1 2019

May 14, 2019

BUY
$27.81 - $40.78 $1.05 Million - $1.54 Million
37,644 Added 9.23%
445,561 $15.2 Million
Q4 2018

Feb 13, 2019

BUY
$28.91 - $50.0 $148,770 - $257,300
5,146 Added 1.28%
407,917 $13 Million
Q3 2018

Nov 13, 2018

BUY
$30.85 - $50.65 $936,729 - $1.54 Million
30,364 Added 8.15%
402,771 $19.3 Million
Q2 2018

Aug 14, 2018

BUY
$13.95 - $32.65 $1.34 Million - $3.13 Million
95,890 Added 34.68%
372,407 $11.5 Million
Q1 2018

May 15, 2018

BUY
$14.35 - $16.5 $27,480 - $31,597
1,915 Added 0.7%
276,517 $4.09 Million
Q4 2017

Feb 13, 2018

BUY
$12.45 - $17.4 $156,247 - $218,369
12,550 Added 4.79%
274,602 $4.26 Million
Q3 2017

Nov 14, 2017

SELL
$10.25 - $12.8 $62,135 - $77,593
-6,062 Reduced 2.26%
262,052 $3.26 Million
Q2 2017

Aug 14, 2017

BUY
N/A
268,114
268,114 $2.9 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.26B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.